Skip to main content
Premium Trial:

Request an Annual Quote

Biocept to Collaborate with UCSD Moores Cancer Center

NEW YORK (GenomeWeb) – Biocept today announced a new collaboration with University of California, San Diego Moores Cancer Center aimed at determining the clinical utility of the company's liquid biopsy technology in detecting biomarkers present in circulating tumor cells and cell-free DNA in the blood of non-small cell lung cancer patients.

Biocept's OncoCEE LU platform and CEE-Selector technology allow highly sensitive, quantitative blood-based detection of cancer mutations, which can be used by clinicians to inform personalized treatment decisions based on genomic information.

OncoCEE LU, launched last fall, detects alterations of the ALK gene in individuals with non-small cell lung cancer. A NSCLC patient's ALK status can help determine whether he or she will respond to ALK inhibitors.

In January, Biocept also announced the launch of two other blood-based tests for NSCLC patients through its CLIA-certified and CAP-accredited laboratory — an EGFR mutation assay, and a test for ROS1 rearrangements.  

Hatim Husain, an assistant professor of hematology-oncology at the Moores Cancer Center, said in a statement that obtaining biopsies in NSCLC is "a serious clinical challenge" in treating the disease.

"A blood-based liquid biopsy could reduce the need to conduct lung tissue biopsies, and also offers the ability to obtain critical genomic information for improved patient management on a more frequent basis," he added.

The Scan

Close Panel Vote on Califf Nomination

The New York Times reports there was a close committee vote to advance the nomination of Robert Califf to lead the US Food and Drug Administration to the full Senate.

Task Force Reports on Scientific Integrity

Nature News writes that that a new task force report recommends that the US establish a cross-agency scientific integrity council.

Across the Hall

Genetic testing, closed-circuit cameras, and more show how a traveler, without any contact, infected others at a New Zealand quarantine facility, CNN reports.

Science Paper Examines Influence of Chromatin Modifications on Obsessive-Compulsive Disorder

In Science this week: genes regulating chromatin modification may contribute to OCD risk.